Single-dose Pharmacokinetics and Relative Bioavailability of Two Different Formulations of Opicapone
Status:
Completed
Trial end date:
2014-03-01
Target enrollment:
Participant gender:
Summary
Single-centre, open-label, randomised, two-way crossover study in 28 healthy volunteers. The
study consisted of two consecutive single-dose treatment periods separated by a washout
period of 14 days or more.